Mike Nedokovic
Analyst
TD Cowen
Equibles does not estimate personal net worth.
About Mike Nedokovic
Mike Nedokovic is recorded as Analyst at TD Cowen. Mike Nedokovic has spoken on 2 earnings calls across 1 company, most recently for Coherus Oncology, Inc. on May 11, 2026. The companies whose calls Mike Nedokovic spoke on are classified in the Healthcare sector.
Mike Nedokovic on recent calls
“I'll start with my first on TAGMO-KITUG. Theresa, you alluded to this in your remarks, but I believe Lenovo has initiated a Phase 3 trial for its CCR8 antibody.”
“I believe the frontline HCC trial is randomized, but not blinded. So, I'm curious if you're tracking responses, and if so, is what you're seeing giving you more or less confidence in Kezdozo's outlook?”
Affiliation history
-
TD Cowen
Analyst
Transcript header (unverified)
Current